Shared Care Guideline

Guanfacine for the management of Attention-Deficit Hyperactivity Disorder (ADHD)- Children & Young People (5-17 years of age)

Guideline added to website on: 10/05/20
Last modified on: 27/07/21
CCG: |
Tags: adhd, attention, Children, deficit, disorder, guanfacine, hypersensitivity, young

Currently under review - please contact medicines optimisation team for more details


Scroll to Top